In summary, patients on PD have a vastly increased risk of cardiovascular disease. Volume overload plays a major role in its pathogenesis. Sodium restriction therefore must be advised in PD patients and supported by a patient education programme. Normovolaemia can be achieved through increased ultrafiltration rate using icodextrin or by increasing residual urine volume with loop-diuretics. Care must be taken to prevent underfilling and the preservation of RRF is crucial. Although it is tempting to assume that the survival benefit of non-dialysis patients on statin treatment will also translate to the PD population, the outcome of ongoing prospective trials is anxiously awaited. Finally, although PD may offer a survival advantage in patients initiating RRT [20,48], PD is currently under-utilized in many parts of the world [50].